Cargando…

A Pilot Survey Study of Adherence to Care Considerations for Duchenne Muscular Dystrophy

Introduction Care Considerations supported by the Centers for Disease Control and Prevention for the management of Duchenne muscular dystrophy were published in 2010, but there has been limited study of implementation in the United States. Methods A questionnaire collecting information about standar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Kristin, Trout, Christina, Westfield, Christina, Fox, Deborah, Pandya, Shree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Muscular Dystrophy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128678/ https://www.ncbi.nlm.nih.gov/pubmed/30254788 http://dx.doi.org/10.1371/currents.md.5f533e6e60ee172d6bf6b2b8375dfadf

Ejemplares similares

Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey
por: Paramsothy, Pangaja, et al.
Publicado: (2018)

Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
por: Larkindale, Jane, et al.
Publicado: (2017)

Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016)

Clinic-Based Infant Screening for Duchenne Muscular Dystrophy: A Feasibility Study
por: Cyrus, Alissa, et al.
Publicado: (2012)

Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences
por: Henricson, Erik, et al.
Publicado: (2012)

The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys
por: Pane, Marika, et al.
Publicado: (2014)

The Effect of 6-Thioguanine on Alternative Splicing and Antisense-Mediated Exon Skipping Treatment for Duchenne Muscular Dystrophy
por: Verhaart, Ingrid E. C., et al.
Publicado: (2012)

Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?
por: Sienko, Susan, et al.
Publicado: (2016)

Collective Statement Regarding Patient Access to Approved Therapies from the Center Directors of Parent Project Muscular Dystrophy’s Certified Duchenne Care Centers
por: Ionita, Cristian, et al.
Publicado: (2018)

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011)

New Recommendation on Biological Materials Could Hamper Muscular Dystrophy Research
por: McCormack, Pauline, et al.
Publicado: (2016)

DuchenneConnect Registry Report
por: Rangel, Vanessa, et al.
Publicado: (2012)

Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy
por: Berger, Dara S., et al.
Publicado: (2012)

Alterations in the expression of leukemia inhibitory factor following exercise: comparisons between wild-type and mdx muscles
por: Hunt, Liam C, et al.
Publicado: (2011)

Speckle tracking analysis of the left ventricular anterior wall shows significantly decreased relative radial strain patterns in dystrophin deficient mice after 9 months of age
por: Spurney, Christopher, et al.
Publicado: (2012)

Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype
por: Smythe, Gayle M, et al.
Publicado: (2012)

Restoration of dystrophin expression using the Sleeping Beauty transposon
por: Muses, Sofia, et al.
Publicado: (2012)

The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice.
por: Radley-Crabb, Hannah G, et al.
Publicado: (2011)

Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success
por: Pichavant, Christophe, et al.
Publicado: (2011)

Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages
por: Wang, Bo, et al.
Publicado: (2011)

Human satellite cells: identification on human muscle fibres
por: Boldrin, Luisa, et al.
Publicado: (2012)

Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy
por: Philippi, Susanne, et al.
Publicado: (2012)

Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: “Translating“ the Translational
por: McCormack, Pauline, et al.
Publicado: (2013)

Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases
por: Han, Jay J., et al.
Publicado: (2013)

The Effects of Glucocorticoid and Voluntary Exercise Treatment on the Development of Thoracolumbar Kyphosis in Dystrophin-Deficient Mice
por: Brereton, Daniel, et al.
Publicado: (2012)

Proof of Concept of the Ability of the Kinect to Quantify Upper Extremity Function in Dystrophinopathy
por: Lowes, Linda P, et al.
Publicado: (2013)

Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice
por: Spitali, Pietro, et al.
Publicado: (2013)

Increased taurine in pre-weaned juvenile mdx mice greatly reduces the acute onset of myofibre necrosis and dystropathology and prevents inflammation
por: Terrill, Jessica R., et al.
Publicado: (2016)

Are Soy Products Effective in DMD?
por: Winder, Steve J, et al.
Publicado: (2018)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

An update on Becker muscular dystrophy
por: Straub, Volker, et al.
Publicado: (2023)

Palliative care services in families of males with muscular dystrophy: Data from MD STARnet
por: Andrews, Jennifer G, et al.
Publicado: (2019)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy
por: Griggs, Robert C., et al.
Publicado: (2016)

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials
por: Ricotti, Valeria, et al.
Publicado: (2016)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_th2bp0thuarkh89fnaq3tvle6u